TRexBio

TRexBio

Pre-clinical
South San Francisco, United StatesFounded 2019trex.bio

TRexBio is creating purpose-built biologics aimed at restoring immune balance in autoimmune and inflammatory diseases. By addressing the disease where it presents, in the tissue, our goal is to quiet the inflammatory process and restore tissue homeostasis.

Market Cap
Private
Pipeline
Patents
Publications

Private Company

Total funding raised: $69M

About

TRexBio is creating purpose-built biologics aimed at restoring immune balance in autoimmune and inflammatory diseases. By addressing the disease where it presents, in the tissue, our goal is to quiet the inflammatory process and restore tissue homeostasis.

ImmunologyOncology

Funding History

2
Total raised:$69M
Series A$59MMar 15, 2021
Seed$10MJun 15, 2019